[go: up one dir, main page]

SE0602571L - Känslig detektion av gifter, patogener och sjukdomsmarkörer genom aggregation av cytoskeletala filament - Google Patents

Känslig detektion av gifter, patogener och sjukdomsmarkörer genom aggregation av cytoskeletala filament

Info

Publication number
SE0602571L
SE0602571L SE0602571A SE0602571A SE0602571L SE 0602571 L SE0602571 L SE 0602571L SE 0602571 A SE0602571 A SE 0602571A SE 0602571 A SE0602571 A SE 0602571A SE 0602571 L SE0602571 L SE 0602571L
Authority
SE
Sweden
Prior art keywords
toxins
pathogens
aggregation
sensitive detection
disease markers
Prior art date
Application number
SE0602571A
Other languages
English (en)
Other versions
SE531135C2 (sv
Inventor
Alf Maansson
Sven Taagerud
Original Assignee
Alf Maansson
Sven Taagerud
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alf Maansson, Sven Taagerud filed Critical Alf Maansson
Priority to SE0602571A priority Critical patent/SE531135C2/sv
Priority to EP07852077.2A priority patent/EP2092343B1/en
Priority to PCT/SE2007/001071 priority patent/WO2008066463A1/en
Priority to US12/517,148 priority patent/US8658381B2/en
Publication of SE0602571L publication Critical patent/SE0602571L/sv
Publication of SE531135C2 publication Critical patent/SE531135C2/sv

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/58—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances
    • G01N33/585—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving labelled substances with a particulate label, e.g. coloured latex
    • G01N33/586—Liposomes, microcapsules or cells
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
    • C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
    • C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
    • C07K14/4716—Muscle proteins, e.g. myosin, actin
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K19/00—Hybrid peptides, i.e. peptides covalently bound to nucleic acids, or non-covalently bound protein-protein complexes
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/536—Immunoassay; Biospecific binding assay; Materials therefor with immune complex formed in liquid phase
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Molecular Biology (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Biomedical Technology (AREA)
  • Urology & Nephrology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Analytical Chemistry (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • Food Science & Technology (AREA)
  • Toxicology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Zoology (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analyzing Materials By The Use Of Electric Means (AREA)
  • Investigating, Analyzing Materials By Fluorescence Or Luminescence (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
SE0602571A 2006-12-01 2006-12-01 Känslig detektion av gifter, patogener och sjukdomsmarkörer genom aggregation av cytoskeletala filament SE531135C2 (sv)

Priority Applications (4)

Application Number Priority Date Filing Date Title
SE0602571A SE531135C2 (sv) 2006-12-01 2006-12-01 Känslig detektion av gifter, patogener och sjukdomsmarkörer genom aggregation av cytoskeletala filament
EP07852077.2A EP2092343B1 (en) 2006-12-01 2007-11-30 Detection conjugate
PCT/SE2007/001071 WO2008066463A1 (en) 2006-12-01 2007-11-30 Detection conjugate
US12/517,148 US8658381B2 (en) 2006-12-01 2007-11-30 Detection conjugate

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0602571A SE531135C2 (sv) 2006-12-01 2006-12-01 Känslig detektion av gifter, patogener och sjukdomsmarkörer genom aggregation av cytoskeletala filament

Publications (2)

Publication Number Publication Date
SE0602571L true SE0602571L (sv) 2008-06-02
SE531135C2 SE531135C2 (sv) 2008-12-23

Family

ID=39468162

Family Applications (1)

Application Number Title Priority Date Filing Date
SE0602571A SE531135C2 (sv) 2006-12-01 2006-12-01 Känslig detektion av gifter, patogener och sjukdomsmarkörer genom aggregation av cytoskeletala filament

Country Status (4)

Country Link
US (1) US8658381B2 (sv)
EP (1) EP2092343B1 (sv)
SE (1) SE531135C2 (sv)
WO (1) WO2008066463A1 (sv)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9909167B2 (en) 2014-06-23 2018-03-06 The Board Of Trustees Of The Leland Stanford Junior University On-slide staining by primer extension
WO2018022809A1 (en) 2016-07-27 2018-02-01 The Board Of Trustees Of The Leland Stanford Junior University Highly-multiplexed fluorescent imaging
US20190170737A1 (en) * 2016-09-19 2019-06-06 Massachusetts Institute Of Technology Systems including janus droplets
MY204234A (en) 2018-08-27 2024-08-16 Regeneron Pharma Use of raman spectroscopy in downstream purification
US20220163537A1 (en) * 2019-03-26 2022-05-26 Fast Bt Ug Detection and Quantification of Molecular Species
US12274993B2 (en) 2019-09-18 2025-04-15 Massachusetts Institute Of Technology Systems and methods for affecting interactions of electromagnetic radiation with janus droplets for sensitive detection of species

Also Published As

Publication number Publication date
EP2092343B1 (en) 2014-08-20
US20100248212A1 (en) 2010-09-30
SE531135C2 (sv) 2008-12-23
EP2092343A4 (en) 2010-06-02
WO2008066463A1 (en) 2008-06-05
EP2092343A1 (en) 2009-08-26
US8658381B2 (en) 2014-02-25

Similar Documents

Publication Publication Date Title
CY1123496T1 (el) Μεθοδοι για την ανιχνευση συμμετρικης διμεθυλαργινινης
CL2008001175A1 (es) Metodo para distinguir semillas que contienen un elemento genetico de interes a partir de una muestra de un lote,basado en la presencia de una proteina marcadora fluorescente roja.
MX2012004310A (es) Metodo para caracterizar almenos un microorganismo por medio de espectrometria de masa.
MX367366B (es) Composiciones y metodos para diagnosticar tumores de tiroides.
MX2010004615A (es) Anticuerpos monoclonales contra proteina c. activada e inactivada.
ATE483825T1 (de) Zusammensetzungen für die identifizierung von adenoviren
ATE548374T1 (de) 2'-fluor-2'-desoxytetrahydrouridine als cytidindeaminaseinhibitoren
CY1112798T1 (el) Ενωσεις διαρυλυδαντοϊνης
EA200900781A1 (ru) 4-фенилпиран-3,5-дионы, 4-фенилтиопиран-3,5-дионы и циклогексантрионы, как новые гербициды
CY1113190T1 (el) Μεθοδος αγωγης της αιμολυτικης νοσου
GT201200132A (es) Antagonistas il-17a
ATE544870T1 (de) Profilierung einer rezeptorfamilie
DK2021794T3 (da) Anvendelse af protein S100A 12 som en markør for colorektal cancer
BR112014021477A2 (pt) anticorpos para metaloproteinase de matriz 9
CY1115960T1 (el) Θεραπευτικη αγωγη ογκων χρησιμοποιωντας ειδικο αντισωμα anti-l1
EA201170636A1 (ru) Антагонисты толл-подобного рецептора 3
WO2008034016A3 (en) Assays for detecting native-state proteins and identifying compounds that modulate the stability of native-state proteins
CY1113485T1 (el) Ενωσεις γεφυρωμενης-πιπεριδινης τυπου υποκατεστημενης-κινοξαλινης και οι χρησεις εξ' αυτων
DE602006019964D1 (de) Reinigung von montelukast
DE602006020544D1 (de) Apolipoprotein-a-ii-isoform als biomarker für prostatakrebs
TR200801440T1 (tr) Hastalığa direnci geliştirilmiş kabak bitkisi
DE602006021223D1 (de) Verfahren zur identifizierung von trpv2-modulatoren
EP2074427A4 (en) Diagnostic biomolecule(s)
SE0602571L (sv) Känslig detektion av gifter, patogener och sjukdomsmarkörer genom aggregation av cytoskeletala filament
EP2295979A3 (en) Protein detection reagents and methods with dyes and dextrins

Legal Events

Date Code Title Description
NUG Patent has lapsed